[ad_1]
NEW YORK (Reuters Health) – Depression, obesity and chronic pain can be addressed by targeting a protein, according to a recent German study.
The researchers found that the blocking protein called "FKBP51" in mice relieved chronic pain, promoted mood and promoted weight loss.
A study by a scientific team at the Technical University of Darmstadt, Germany, is the first study to target a specific protein, without affecting the functions of other body proteins, according to a report by Daily Mail.
The researchers hope that their studies will lead to new treatments in humans.
"FKBP51 plays an important role in depression, obesity, diabetes and chronic pain," said Dr. Felix Hausch, who led the study.
View related news
"We have developed the first faulty FKBP51, an extremely powerful and highly selective SAFit2, and it is now tested on mice."
He pointed out that the new protein inhibitor could constitute a new therapeutic option to treat all these cases, since it controls the functions of the FKBP51 protein, which affects all parts of the body, including the brain, the musculoskeletal tissues. skeletal and fat, as well as its role in regulating glucose uptake in stress management. .
The full results will be presented at the 2019 conference of the American Chemical Society in Orlando.
This article is a "unique protein responsible for depression, obesity and chronic pain". It does not come from the site of the press agent. It does not reflect in any way the site policy or the opinion point of view. The responsibility is related to the news or the authenticity of the source of information.
[ad_2]
Source link
